Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Clinical and economic impact of a pharmacist-managed i.v.-to-p.o. conversion service for levofloxacin in Taiwan.

Yen YH, Chen HY, Wuan-Jin L, Lin YM, Shen WC, Cheng KJ.

Int J Clin Pharmacol Ther. 2012 Feb;50(2):136-41.

PMID:
22257579
2.

Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral.

Kuti JL, Le TN, Nightingale CH, Nicolau DP, Quintiliani R.

Am J Health Syst Pharm. 2002 Nov 15;59(22):2209-15.

PMID:
12455304
3.

Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.

File TM Jr, Milkovich G, Tennenberg AM, Xiang JX, Khashab MM, Zadeikis N.

Curr Med Res Opin. 2004 Sep;20(9):1473-81.

PMID:
15383197
5.

Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital.

Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, Yan T.

Int J Clin Pharm. 2011 Dec;33(6):929-33. doi: 10.1007/s11096-011-9577-z. Epub 2011 Nov 9.

PMID:
22068326
6.

Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.

Clark LC, Davis CW.

Am J Health Syst Pharm. 2000 Nov 15;57 Suppl 3:S10-3.

PMID:
11098314
7.

A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.

Curr Med Res Opin. 2008 Mar;24(3):895-906. doi: 10.1185/030079908X273408.

PMID:
18419876
8.

Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.

Dunn K, O'Reilly A, Silke B, Rogers T, Bergin C.

Int J Clin Pharm. 2011 Apr;33(2):208-14. doi: 10.1007/s11096-010-9475-9. Epub 2011 Jan 25.

PMID:
21744190
9.

Approaches to drug therapy, formulary, and pathway management in a large community hospital.

Halley HJ.

Am J Health Syst Pharm. 2000 Nov 15;57 Suppl 3:S17-21.

PMID:
11098316
10.

Effects of pharmaceutical counselling on antimicrobial use in surgical wards: intervention study with historical control group.

Grill E, Weber A, Lohmann S, Vetter-Kerkhoff C, Strobl R, Jauch KW.

Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):739-46. doi: 10.1002/pds.2126. Epub 2011 Mar 30.

PMID:
21452339
11.

Clinical and economic impact of a pharmacist-intervention to promote sequential intravenous to oral clindamycin conversion.

Martínez MJ, Freire A, Castro I, Inaraja MT, Ortega A, Del Campo V, Rodriguez I, Bardán B, Morano LE, Garcia JF.

Pharm World Sci. 2000 Apr;22(2):53-8.

PMID:
10849923
12.
13.

Antibiotic optimization. An evaluation of patient safety and economic outcomes.

Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS.

Arch Intern Med. 1997 Aug 11-25;157(15):1689-94. Erratum in: Arch Intern Med 1997 Nov 24;157(21):2487.

PMID:
9250230
14.

Pharmacist-managed intravenous to oral step-down program.

Hunter KA, Dormaier GK.

Clin Ther. 1995 May-Jun;17(3):534-40; discussion 516.

PMID:
7585857
15.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
16.

Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.

Hall D, Buchanan J, Helms B, Eberts M, Mark S, Manolis C, Peele P, Docimo A.

Pharmacotherapy. 2011 Jul;31(7):686-94. doi: 10.1592/phco.31.7.686.

PMID:
21923456
17.

Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.

Wang J, Dong M, Lu Y, Zhao X, Li X, Wen A.

Int J Clin Pharmacol Ther. 2015 Aug;53(8):605-15. doi: 10.5414/CP202334.

PMID:
26104036
18.
19.

Impact of a pharmacy resident on hospital length of stay and drug-related costs.

Terceros Y, Chahine-Chakhtoura C, Malinowski JE, Rickley WF.

Ann Pharmacother. 2007 May;41(5):742-8. Epub 2007 Apr 17.

PMID:
17440008
20.

Economic evaluation of oral ofloxacin versus standard parenteral therapy in the treatment of pneumonia.

Menzin J, Huse DM, Richner R, Oster G.

Pharmacoeconomics. 1992 Aug;2(2):171-7.

PMID:
10146956

Supplemental Content

Support Center